Zevra Therapeutics, Inc. (ZVRA) Stock Total Returns
Growth of $10,000 chart
2021-04-21 to 2026-04-21 to
$
%
%
Loading chart…
Investment Performance
Final Value
$11,648
Total Return
16.48%
CAGR
3.10%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | +1.36% |
| Median | -0.50% |
| Best | +84.98% |
| Worst | -32.75% |
| % of Windows Positive | 48.7% |
1-Year (252 Trading Days)
| Average | +10.74% |
| Median | +8.15% |
| Best | +182.16% |
| Worst | -72.66% |
| % of Windows Positive | 58.6% |
3-Year (756 Trading Days)
| Average | +35.50% |
| Median | +46.43% |
| Best | +179.26% |
| Worst | -71.82% |
| % of Windows Positive | 66.9% |
Risk Metrics
| Maximum Drawdown | -74.01% |
| Average Drawdown | -52.85% |
| Drawdown Duration | 1214 Trading Days (Unrecovered) |
| Sortino Ratio | 0.52 |
| Calmar Ratio | 0.04 |
| CVaR (5%) | -8.10% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +15.96% (+62.78% ann.) | +$1596.00 | $0.00 | $0.00 | $0.00 |
| 2025 | +7.43% | +$743.45 | $0.00 | $0.00 | $0.00 |
| 2024 | +27.33% | +$2732.89 | $0.00 | $0.00 | $0.00 |
| 2023 | +42.70% | +$4269.93 | $0.00 | $0.00 | $0.00 |
| 2022 | -47.30% | $4730.17 | $0.00 | $0.00 | $0.00 |
| 2021 | -22.23% | $2223.20 | $0.00 | $0.00 | $0.00 |
| 2020 | +84.70% | +$8469.81 | $0.00 | $0.00 | $0.00 |
| 2019 | -78.71% | $7870.81 | $0.00 | $0.00 | $0.00 |
| 2018 | -56.05% | $5604.92 | $0.00 | $0.00 | $0.00 |
| 2017 | +37.29% | +$3728.80 | $0.00 | $0.00 | $0.00 |
| 2016 | -85.15% | $8514.60 | $0.00 | $0.00 | $0.00 |
| 2015 partial | +77.32% (+124.29% ann.) | +$7732.14 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | April 16, 2015 – February 19, 2020 | -96.80% | -50.86% | $9680.36 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -43.40% | -99.85% | $4339.62 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +195.35% | +471.21% | +$19535.32 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -23.24% | -22.19% | $2324.17 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -31.54% | -33.13% | $3154.44 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | +63.34% | +30.31% | +$6334.31 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – April 21, 2026 | +32.70% | +19.50% | +$3269.56 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.